Last 12 months
Inside the activity.
0 purchase rows · 93 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 16 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 49 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 30, 2008 Filed Jul 31, 2008 19:16 UTC |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 2,584 | $32.38 | $83,669.92 |
DisclosureSEC source: 0000875320-08-000062 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,594 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.38 (range $31.58 to $32.57). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 30, 2008 Filed Jul 31, 2008 19:16 UTC |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000062 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2008 Filed Aug 7, 2008 16:47 UTC Amendment |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 9,816 | $32.91 | $323,044.56 |
DisclosureSEC source: 0000875320-08-000064 · edgar.xml · nonDerivative · entry 3 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $32.91 (range $32.59 to $33.25). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · balance_after: Amount of securities beneficially owned following reported transaction was incorrect in original filing. Read SEC document |
| July 30, 2008 Filed Aug 7, 2008 16:47 UTC Amendment |
BOGER JOSHUA SDirector · President & CEO
|
SaleCommon Stock | 2,584 | $32.38 | $83,669.92 |
DisclosureSEC source: 0000875320-08-000064 · edgar.xml · nonDerivative · entry 2 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,104,860 F1 · kind: Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.38 (range $31.58 to $32.57). F4 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. F5 · balance_after: Amount of securities beneficially owned following reported transaction was incorrect in original filing. Read SEC document |
| July 30, 2008 Filed Aug 7, 2008 16:47 UTC Amendment |
BOGER JOSHUA SDirector · President & CEO
|
Exercise / conversionCommon Stock | 12,400 | $10.19 | $126,356.00 |
DisclosureSEC source: 0000875320-08-000064 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · balance_after: Amount of securities beneficially owned following reported transaction was incorrect in original filing. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 14:56 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
GrantStock Options · Derivative | 36,250 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000052 · edgar.xml · derivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 36,250 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 14:57 UTC |
BOGER KENNETH SSVP & General Counsel
|
GrantStock Options · Derivative | 30,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000053 · edgar.xml · derivative · entry 1 BOGER KENNETH S · CIK 0001046336 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:01 UTC |
BOGER JOSHUA SDirector · President & CEO
|
GrantStock Options · Derivative | 118,000 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000054 · edgar.xml · derivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,000 Underlying: Common Stock · 118,000 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:04 UTC |
POWER JOHANNA MESSINAVP & Controller
|
GrantStock Options · Derivative | 7,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000055 · edgar.xml · derivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:06 UTC |
SMITH IAN FEVP & CFO
|
GrantStock Options · Derivative | 36,250 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000056 · edgar.xml · derivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 36,250 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:07 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
GrantStock Options · Derivative | 36,250 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000057 · edgar.xml · derivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 36,250 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:11 UTC |
GARRISON RICHARD CSVP and Catalyst
|
GrantStock Options · Derivative | 30,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000058 · edgar.xml · derivative · entry 1 GARRISON RICHARD C · CIK 0001256466 · SVP and Catalyst 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:12 UTC |
Kelly LisaSVP, Human Resources
|
GrantStock Options · Derivative | 30,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000059 · edgar.xml · derivative · entry 1 Kelly Lisa · CIK 0001349077 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:14 UTC |
Graves KurtEVP, Chief Commercial Officer
|
GrantStock Options · Derivative | 36,250 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000060 · edgar.xml · derivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,250 Underlying: Common Stock · 36,250 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 24, 2008 Filed Jul 25, 2008 15:15 UTC |
Sachdev AmitSVP, Public Policy,Gov Affairs
|
GrantStock Options · Derivative | 30,500 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000061 · edgar.xml · derivative · entry 1 Sachdev Amit · CIK 0001406338 · SVP, Public Policy,Gov Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,500 Underlying: Common Stock · 30,500 shares Expires 2018-07-23 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. Read SEC document |
| July 21, 2008 Filed Jul 23, 2008 16:10 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 2,325 | $32.71 | $76,050.75 |
DisclosureSEC source: 0000875320-08-000051 · edgar.xml · nonDerivative · entry 2 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,649 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.71 (range $32.54 to $32.94). F3 · price: Mr. Graves undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 21, 2008 Filed Jul 23, 2008 16:10 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 600 | $31.89 | $19,134.00 |
DisclosureSEC source: 0000875320-08-000051 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,974 F1 · kind: Transaction made pursuant to Mr. Graves' company approved trading plan under Rule 10b5-1. Read SEC document |
| July 15, 2008 Filed Jul 17, 2008 16:37 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionStock Option · Derivative | 2,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000050 · edgar.xml · derivative · entry 5 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 2,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Fully vested. Read SEC document |
| July 15, 2008 Filed Jul 17, 2008 16:37 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 1,200 | $32.21 | $38,652.00 |
DisclosureSEC source: 0000875320-08-000050 · edgar.xml · nonDerivative · entry 3 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,390 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F3 · price: Open market sales reported on this line occurred at a weighted average price of $32.21 (range $32.08 to $32.33). F4 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2008 Filed Jul 17, 2008 16:37 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
SaleCommon Stock | 1,200 | $32.59 | $39,108.00 |
DisclosureSEC source: 0000875320-08-000050 · edgar.xml · nonDerivative · entry 2 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,590 F1 · kind: Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. F2 · price: Open market sales reported on this line occurred at a weighted average price of $32.59 (range $32.38 to $33.10). F4 · price: Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Read SEC document |
| July 15, 2008 Filed Jul 17, 2008 16:37 UTC |
MUELLER PETEREVP Drug Innov.& Realiz, CSO
|
Exercise / conversionCommon Stock | 2,400 | $9.07 | $21,768.00 |
DisclosureSEC source: 0000875320-08-000050 · edgar.xml · nonDerivative · entry 1 MUELLER PETER · CIK 0001256126 · EVP Drug Innov.& Realiz, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 10,125 | $0.00 Strike: $17.16 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 18 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,875 Underlying: Common Stock · 10,125 shares Expires 2015-07-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 2,700 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 17 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,050 Underlying: Common Stock · 2,700 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 21,600 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 16 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,600 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 14,400 | $0.00 Strike: $9.07 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 15 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,400 shares Expires 2013-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 3,715 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 14 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,715 shares Expires 2013-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 4,821 | $0.00 Strike: $15.87 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 13 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,821 shares Expires 2012-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $24.66 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 12 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2011-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionStock Option · Derivative | 19,075 | $0.00 Strike: $26.20 | $0.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · derivative · entry 11 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,075 shares Expires 2011-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
SaleCommon Stock | 81,436 | $35.00 | $2,850,260.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 9 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,301 F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan established under Rule 10b5-1. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 10,125 | $17.16 | $173,745.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 8 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 2,700 | $10.41 | $28,107.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 7 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 21,600 | $9.69 | $209,304.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 6 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 14,400 | $9.07 | $130,608.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 5 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 3,715 | $15.60 | $57,954.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 4 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,912 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 4,821 | $15.87 | $76,509.27 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 3 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 5,000 | $24.66 | $123,300.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 2 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 09, 2008 Filed Jul 11, 2008 13:56 UTC |
SMITH IAN FEVP & CFO
|
Exercise / conversionCommon Stock | 19,075 | $26.20 | $499,765.00 |
DisclosureSEC source: 0000875320-08-000049 · edgar.xml · nonDerivative · entry 1 SMITH IAN F · CIK 0001197032 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2008 Filed Jul 2, 2008 15:00 UTC |
SACHS BRUCE IDirector
|
GiftCommon Stock | 64,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-08-000048 · edgar.xml · nonDerivative · entry 1 SACHS BRUCE I · CIK 0001197036 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,710 F1 · shares: Common stock gifted to a charitable entity. Read SEC document |
| June 27, 2008 Filed Jun 30, 2008 18:56 UTC |
BOGER JOSHUA SDirector · Chairman, President & CEO
|
GiftCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000875320-08-000047 · edgar.xml · nonDerivative · entry 1 BOGER JOSHUA S · CIK 0001197023 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,095,044 F1 · shares: Common stock gifted to a variety of non-profit entities. Read SEC document |
| June 19, 2008 Filed Jun 23, 2008 15:21 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 3,459 | $0.00 Strike: $15.60 | $0.00 |
DisclosureSEC source: 0000875320-08-000046 · edgar.xml · derivative · entry 5 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,459 shares Expires 2013-01-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| June 19, 2008 Filed Jun 23, 2008 15:21 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionStock Option · Derivative | 4,822 | $0.00 Strike: $15.87 | $0.00 |
DisclosureSEC source: 0000875320-08-000046 · edgar.xml · derivative · entry 4 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,822 shares Expires 2012-07-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years. Read SEC document |
| June 19, 2008 Filed Jun 23, 2008 15:21 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 3,459 | $15.60 | $53,960.40 |
DisclosureSEC source: 0000875320-08-000046 · edgar.xml · nonDerivative · entry 2 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2008 Filed Jun 23, 2008 15:21 UTC |
ALAM JOHN JEVP, Med. Dev. Group & CMO
|
Exercise / conversionCommon Stock | 4,822 | $15.87 | $76,525.14 |
DisclosureSEC source: 0000875320-08-000046 · edgar.xml · nonDerivative · entry 1 ALAM JOHN J · CIK 0001197014 · EVP, Med. Dev. Group & CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,333 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 18, 2008 Filed Jun 19, 2008 20:45 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
GrantStock Option · Derivative | 100,000 | $0.00 Strike: $33.47 | $0.00 |
DisclosureSEC source: 0000875320-08-000045 · edgar.xml · derivative · entry 3 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2018-06-17 F3 · shares: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments over four years. Read SEC document |
| June 18, 2008 Filed Jun 19, 2008 20:45 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
GrantCommon Stock | 10,000 | $0.01 | $100.00 |
DisclosureSEC source: 0000875320-08-000045 · edgar.xml · nonDerivative · entry 2 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 F2 · shares: Stock grant made under 2006 Stock and Option Plan vesting in eight quarterly installments over two years. Read SEC document |
| June 18, 2008 Filed Jun 19, 2008 20:45 UTC |
Lewis-Hall Freda CEVP, Medicines Development
|
GrantCommon Stock | 35,000 | $0.01 | $350.00 |
DisclosureSEC source: 0000875320-08-000045 · edgar.xml · nonDerivative · entry 1 Lewis-Hall Freda C · CIK 0001437909 · EVP, Medicines Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 F1 · shares: Stock grant made under 2006 Stock and Option Plan vesting in four equal annual installments over four years. Read SEC document |
| June 05, 2008 Filed Jun 9, 2008 16:30 UTC |
Graves KurtEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,549 | $31.05 | $110,196.45 |
DisclosureSEC source: 0000875320-08-000043 · edgar.xml · nonDerivative · entry 1 Graves Kurt · CIK 0001406337 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,574 F1 · kind: Transaction made pursuant to Mr. Grave's company approved trading plan established under Rule 10b5-1. Read SEC document |
| June 01, 2008 Filed Jun 2, 2008 20:38 UTC |
CORDES EUGENEDirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0000875320-08-000035 · edgar.xml · derivative · entry 1 CORDES EUGENE · CIK 0001192609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2018-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2008 Filed Jun 2, 2008 20:40 UTC |
SANDERS CHARLES ADirector
|
GrantStock Option · Derivative | 20,000 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0000875320-08-000036 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2018-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.